Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Summary Hyperinsulinemic hypoglycemia with neuroglycopenia is an increasingly recognized complication of Roux-en-Y gastric bypass (RYGB) due to the changes in gut hormonal milieu. Physicians should be aware of this complication to ensure timely and effective treatment of post-RYGB patients, who present to them with hypoglycemic symptoms. Possible causes of hypoglycemia in these patients include late dumping syndrome, nesidioblastosis and rarely insulinoma. Systematic evaluation including history, biochemical analysis, and diagnostic testing might help in distinguishing among these diagnoses. Continuous glucose monitoring is also a valuable tool, revealing the episodes in the natural environment and can also be used to monitor treatment success. Treatment should begin with strict low carbohydrate diet, followed by medication therapy. Therapy with diazoxide, acarbose, calcium channel blockers and octreotide have been proven to be beneficial, but the response apparently is highly variable. When other treatment options fail, surgical options can be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 2×
“Bariatric surgery is currently the most effective therapy for severe obesity which results in substantial weight loss, averaging 30–40 kg (about 60% excess weight) utilizing the most effective approaches [1].”
BackgroundSeaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 8×
“Qintar M, Sibai F, Taha M. Hypoglycemia due to an adult-onset nesidioblastosis, a diagnostic and management dilemma.”
InfluentialDefining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985
STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649 · cited 1×
“In 1983, Bell and colleagues [48] identified GLP-1 as a cleavage product of the pre-proglucagon gene, and since then it has been shown to function as an even more potent glucose-dependent incretin than GIP [49,50].”
BackgroundMorínigo, R., Moizé, V., Musri, M., Lacy, A. M., Navarro, S., Marín, J. L., Delgado, S., Casamitjana, R., & Vidal, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0904 · Cited by 397
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377 · cited 10×
“Goldfine and colleague [22] found incretin levels to be 5–10 fold higher in postRYGB patients compared to controls.”
BackgroundInfluentialPatti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1933-x · Cited by 365
Korner, J., Bessler, M., Inabnet, W., Taveras, C., & Holst, J. J. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.08.004 · Cited by 344
Korner, J., Inabnet, W., Febres, G., Conwell, I. M., McMahon, D. J., Salas, R., Taveras, C., Schrope, B., & Bessler, M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.79 · Cited by 338
Salehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323
Marsk, R., Jonas, E., Rasmussen, F., & Näslund, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1798-5 · Cited by 273
Meier, J. J., Butler, A. E., Galasso, R., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/dc06-0392 · Cited by 249
Vilarrasa, N., Goday, A., Rubio, M. A., Caixàs, A., Pellitero, S., Ciudin, A., Calañas, A., Botella, J. I., Bretón, I., Morales, M. J., et al. (2016) · Obesity Facts · doi:10.1159/000442764 · Cited by 197
McLaughlin, T., Peck, M., Holst, J., & Deacon, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1628 · Cited by 183
Vezzosi, D., Bennet, A., Fauvel, J., & Caron, P. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0109 · Cited by 152
Clancy, T. E., Moore, F. D., & Zinner, M. J. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.04.008 · Cited by 133 · cited 3×
“There is emerging recognition that post-prandial hypoglycemia in adults after RYGB may be due to hyperinsulinemia from hypertrophied islets as a result of nesidioblastosis [13,22,23].”
BackgroundSevere Recurrent Hypoglycemia after Gastric Bypass Surgery
Z’graggen, K., Guweidhi, A., Steffen, R., Potoczna, N., Biral, R., Walther, F., Komminoth, P., & Horber, F. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9480-4 · Cited by 125 · cited 5×
“Diagnostic imaging can be performed to rule out exocrine and endocrine pancreatic diseases, in particular insulinoma, in post-RYGB patients presenting with hypoglycemia [38,79].”
BackgroundInfluentialPapamargaritis, D., Koukoulis, G., Sioka, E., Zachari, E., Bargiota, A., Zacharoulis, D., & Tzovaras, G. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0711-3 · Cited by 112
Adult diffuse nesidioblastosis: genetically or environmentally induced?
Klöppel, G., Anlauf, M., Raffel, A., Perren, A., & Knoefel, W. T. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.010 · Cited by 108
Tzovaras, G., Papamargaritis, D., Sioka, E., Zachari, E., Baloyiannis, I., Zacharoulis, D., & Koukoulis, G. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0461-7 · Cited by 97 · cited 1×
“Several scoring systems have been developed and used in various studies for diagnosing dumping syndrome including Sigstad’s Diagnostic Index, the Visick classification, and the Arts scoring system [73,74].”
MethodValderas, J. P., Ahuad, J., Rubio, L., Escalona, M., Pollak, F., & Maiz, A. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0581-0 · Cited by 97 · cited 1×
“…et al. (2008) [9] Acarbose Alpha-glucosidase inhibitor 50 mg TID (100–200 mg daily) Oral Kellogg et al. (2008) [14] Hanaire et al. (2009) [39] Valderas et al. (2012) [91] Spanakis et al. (2009) [40] Diazoxide Specific ATP-dependent potassium channel agonist of beta cells 50 mg BID…”
BackgroundVidal, J., Nicolau, J., Romero, F., Casamitjana, R., Momblan, D., Conget, I., Morínigo, R., & Lacy, A. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1620 · Cited by 94
Wiesli, P., Brändle, M., Schmid, C., Krähenbühl, L., Furrer, J., Keller, U., Spinas, G. A., & Pfammatter, T. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000140638.55375.1e · Cited by 93 · cited 1×
“hepatic vein to test for insulin levels [37,84].”
BackgroundRaffel, A., Krausch M, M., Anlauf, M., Wieben, D., Braunstein, S., Klöppel, G., Röher, H.-D., & Knoefel, W. T. (2007) · Surgery · doi:10.1016/j.surg.2006.04.015 · Cited by 81
Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1065 · Cited by 77 · cited 2×
“…agonist of beta cells 50 mg BID Oral Rabiee et al. (2010) [31] Rabiee et al. (2010) [31] Octreotide Somatostatin analog 100 mcg BID Subcutaneous Myint et al. (2012) [15] Moreira et al. (2008) [9] - Verapamil Calcium channel blocker 80 mg BID Oral Hanaire et al. (2009) [39] - Diltiazem -…”
BackgroundButner, K. L., Nickols-Richardson, S. M., Clark, S. F., Ramp, W. K., & Herbert, W. G. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0089-z · Cited by 63
Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia
Mathavan, V. K., Arregui, M., Davis, C., Singh, K., Patel, A., & Meacham, J. (2010) · Surgical Endoscopy · doi:10.1007/s00464-010-1001-6 · Cited by 61 · cited 2×
“Partial, sub-total, and total pancreatic resections have been employed to treat refractory hypoglycemia [23,25,42].”
BackgroundSuccessful Treatment of Persistent Hyperinsulinemic Hypoglycemia with Nifedipine in an Adult Patient
Guseva, N., Phillips, D., & Mordes, J. P. (2010) · Endocrine Practice · doi:10.4158/ep09110.crr · Cited by 35
Hypoglycemia due to an adult-onset nesidioblastosis, a diagnostic and management dilemma
Qintar, M., Sibai, F., & Taha, M. (2012) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.99164 · Cited by 17 · cited 2×
“hepatic vein to test for insulin levels [37,84].”
BackgroundAn unusual cause of hypoglycemia in a middle-aged female after bariatric surgery
Pathak, R., Karmacharya, P., Salman, A., & Alweis, R. (2014) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v4.23118 · Cited by 10
Cited by
le Roux, C. W., & Heneghan, H. M. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.011 · Cited by 139
Cappellani, D., Macchia, E., Falorni, A., & Marchetti, P. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s219438 · Cited by 138
Medical Nutrition Therapy for Post-Bariatric Hypoglycemia: Practical Insights
Suhl, E., Anderson-Haynes, S.-E., Mulla, C., & Patti, M.-E. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.025 · Cited by 96
Llewellyn, D. C., Logan Ellis, H., Aylwin, S. J. B., Oštarijaš, E., Green, S., Sheridan, W., Chew, N. W. S., le Roux, C. W., Miras, A. D., Patel, A. G., et al. (2023) · Obesity · doi:10.1002/oby.23600 · Cited by 54
Metadata
- Authors
- Malik, S., Mitchell, J. E., Steffen, K., Engel, S., Wiisanen, R., Garcia, L., & Malik, S. A.
- Venue
- Obesity Research & Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 10
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1871-403X (ISSN-L)
- OpenAlex
- W1937219258
- Cited by
- 86
- References
- 35
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.